Notably, a study demonstrated that the overexpression of miR-375 in HNSCC cell lines, alongside MTDH knockdown, significantly reduced tumor formation in mice [63], underscoring the critical role of miR-375 in suppressing tumorigenic processes and its potential as a therapeutic target. The gene discussed is MTDH; the disease is head and neck squamous cell carcinoma.